Jean Pascal M.
- Country
- Belgium
- Department
- Medical oncology
Research Overview
- Phase 1 Evaluation of NG-350A and Pembrolizumab in Patients with Metastatic or Advanced Epithelial Tumors
- Investigation of EOS301984 in Adult Patients with Advanced Solid Tumors
- Safety and Tolerability Assessment of Intravenous QEQ278 in Patients with Advanced Non-Small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma, Renal Cell Carcinoma, and Head and Neck Squamous Cell Carcinoma
Data & Insights
Has run more than one trial at 229 of 513 partner sites.
Specializations
Head and Neck Cancer Expertise
The investigator specializes in treating various forms of head and neck squamous cell carcinoma (HNSCC), with particular focus on advanced and metastatic cases. Their research encompasses both early-stage interventions and treatments for recurrent disease.
- First-line treatment strategies
- Immunotherapy combinations
- Radiotherapy interventions
The investigator works with novel therapeutic approaches including peptide-based immunotherapies and targeted treatments for specific patient populations.
Solid Tumor Research
The investigator conducts extensive research in treating advanced solid tumors, with expertise in managing metastatic and refractory cases. Their work includes evaluation of novel therapeutic compounds and combinations targeting specific molecular pathways.
- Advanced malignant tumors
- Epithelial tumors
- KRAS G12C-mutant cancers
Special attention is given to biomarker-driven approaches and precision medicine strategies.
Urological Oncology
The investigator focuses on treating muscle-invasive bladder cancer and advanced urothelial cancer. Their expertise includes both neoadjuvant therapy and treatment of metastatic disease.
- Bladder cancer management
- Combined modality approaches
- Novel therapeutic combinations
Research interests include immunotherapy combinations and targeted treatment strategies for urological malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.